Table of Contents for India: Pharmaceutical and biotechnology opportunities
1. Global collaborative R&D trends
1.1. Falling R&D productivity
1.1.1. Strategies adopted by global pharmaceutical companies to counter falling R&D productivity
1.2. Look East trend
2. The Indian pharmaceutical industry
2.1. Overview
2.2. Market assessment
2.3. Key players in the Indian pharmaceutical market
3. An analysis of the regulatory environment and its implications for R&D
3.1. Regulation in the Indian pharmaceutical industry: A historical perspective
3.2. The changing regulatory environment in India-Advantage R&D
3.3. An analysis of India's changing regulatory framework
3.3.1. Indian Patent Act, 1970
3.3.2. Patents Amendment Act, 2002
3.3.3. The Patents Amendment Ordinance, 2004
3.3.4. Indian Patents (Amendment) Act, 2005
3.3.5. New pharmaceutical policy (2006): Focus on R&D
3.3.5.1. Definitions of R&D
3.3.5.2. Technology upgrade funding
3.4. Response of MNCs to the changing regulatory environment
3.5. Implications for the Indian pharmaceutical industry
3.5.1. Collaborative and contract research and development
3.5.2. In- and out-licensing innovations
4. Collaborative R&D opportunities in India
4.1. Overview
4.2. Engagement models for licensing/purchasing innovation
4.3. Engagement models for contracting research services
4.4. NCE and NDDS research
4.5. Biopharma & drug discovery
4.5.1. Indian biopharma industry
4.5.1.1. Market size estimates: Indian biopharma industry
4.5.1.2. Indian biopharma industry: Vaccines segment
4.5.1.3. Indian biopharma industry: Therapeutics segment
4.5.1.4. Indian biopharma industry: Diagnostics segment
4.5.2. Drug discovery services
4.5.3. Indian biotechnology: Initiatives by the Department of Biotechnology
4.5.3.1. National Biotechnology Development Strategy
4.5.3.1.1. Fiscal and trade policy initiatives
4.5.3.1.2. Financial incentives
4.5.3.1.3. Biotechnology parks
4.5.3.1.4. Regulatory mechanisms
4.5.3.1.5. Create a cadre of resource persons
4.5.3.1.6. Empowering a judiciary
4.5.3.1.7. Industrial mechanisms for strengthening public trust
4.5.3.1.8. Single window
4.5.3.1.9. Innovation
4.5.3.1.10. Strengthening technology transfer capacity
4.5.3.1.11 National Task Force on Education & Training
4.5.3.1.12 Needs assessment
4.5.3.2. Stem cell research policy
4.5.4. Major recent developments in biotechnology
4.6. Bioinformatics.
4.6.1. Market size estimates of Indian bioinformatics industry
4.6.2. Bioinformatics companies in India
4.6.3. Bioinformatics policy of India
4.6.4. Major recent developments in bioinformatics
4.7. Clinical research
4.7.1. Market size estimates of the Indian clinical research industry
4.7.2. Clinical trials: MNC focus on India
4.7.3. Government initiatives to boost clinical research in India
4.7.4. Outsourcing clinical data management to India
4.7.4.1. CROs
4.7.4.2. IT-pharmaceutical ventures
4.7.4.3. Other IT/ITES companies' bio-initiatives
5. Conclusions
6. Company profiles
6.1. NCE/NDDS
6.1.1. Dr Reddy's Laboratories Limited
6.1.1.1. Overview
6.1.1.2. R&D focus
6.1.1.3. Financials
6.1.1.4. Contact information
6.1.2. Glenmark Pharmaceuticals Ltd
6.1.2.1. Overview
6.1.2.2. R&D focus
6.1.2.3. Financials
6.1.2.4. Contact information
6.1.3. Lupin Limited
6.1.3.1. Overview
6.1.3.2. R&D focus
6.1.3.3. Financials
6.1.3.4. Contact information
6.1.4. Nicholas Piramal India Limited
6.1.4.1. Overview
6.1.4.2. R&D focus
6.1.4.3. R&D collaborations
6.1.4.4. Financials
6.1.4.5. Contact information
6.1.5. Ranbaxy Laboratories Limited
6.1.5.1. Overview
6.1.5.2. R&D focus
6.1.5.3. Financials
6.1.5.4. Contact information
6.1.6.Wockhardt Limited
6.1.6.1. Overview
6.1.6.2. R&D focus
6.1.6.3. Financials
6.1.6.4. Contact information
6.1.7. Zydus Cadila
6.1.7.1. Overview
6.1.7.2. R&D focus
6.1.7.3. Financials
6.1.7.4. Contact information
6.2. Bioinformatics
6.2.1. Avestha Gengraine Technologies Pvt. Ltd.
6.2.1.1. Overview
6.2.1.2. Products and services
6.2.1.3. Customer deals
6.2.1.4. Contact information
6.2.2. Jubilant Biosys Ltd
6.2.2.1. Overview
6.2.2.2. Products and services
6.2.2.3. Customer deals
6.2.2.4. Contact information
6.2.3. Molecular Connections Private Limited
6.2.3.1. Overview
6.2.3.2. Products and services
6.2.3.3. Customer deals
6.2.3.4. Contact information
6.2.4. Ocimum Biosolutions Ltd
6.2.4.1. Overview
6.2.4.2. Products and services
6.2.4.3. Customer deals
6.2.4.4. Contact information
6.2.5. Strand Genomics
6.2.5.1. Overview
6.2.5.2. Products and services
6.2.5.3. Customer deals
6.2.5.4. Contact information
6.2.6. SysArris Software Pvt. Ltd
6.2.6.1. Overview
6.2.6.2. Products and services
6.2.6.3. Customer deals
6.2.6.4. Contact information
6.2.7. Bigtec Private Ltd.
6.2.7.1. Overview
6.2.7.2. Products and services
6.2.7.3. Customer deals
6.2.7.4. Contact information
6.2.8. LabVantage Solutions Private Ltd
6.2.8.1. Overview
6.2.8.2. Products and services
6.2.8.3. Customer deals
6.2.8.4. Contact information
6.3. Biopharma & drug discovery services
6.3.1. Aurigene Discovery Technologies Limited
6.3.1.1. Overview
6.3.1.2. Products and services
6.3.1.3. Contact information
6.3.2. Syngene International Private Limited
6.3.2.1. Overview
6.3.2.2. Products and services
6.3.2.3. Customer deals
6.3.2.4. Contact information
6.3.3. Reliance Research and Development Services
6.3.3.1. Overview
6.3.3.2. Products and services
6.3.3.3. Contact information
6.3.4. Reliance Life Sciences
6.3.4.1. Overview
6.3.4.2. Products and services
6.3.4.3. Contact information
6.4. Clinical Research
6.4.1. Clinigene International Private Limited
6.4.1.1. Overview
6.4.1.2. Products and services
6.4.1.3. Contact information
6.4.2. iGATE Clinical Research International
6.4.2.1. Overview
6.4.2.2. Products and services
6.4.2.3. Contact information
6.4.3. SIRO Clinpharm Pvt. Ltd.
6.4.3.1. Overview
6.4.3.2. Products and services
6.4.3.3. Contact information
6.4.4. Wellquest CRO
6.4.4.1. Overview
6.4.4.2. Products and services
6.4.4.3. Contact information
6.4.5. Reliance Clinical Research Services
6.4.5.1. Overview
6.4.5.2. Products and services
6.4.5.3. Contact information
6.4.6. ClinTec International
6.4.6.1. Overview
6.4.6.2. Products and services
6.4.6.3. Contact information
6.4.7. Quintiles India
6.4.7.1. Overview
6.4.7.2. Products and services
6.4.7.3. Contact information
7. Life science research institute profiles
7.1. Central Drug Research Institute
7.1.1. Overview
7.1.2. R&D focus
7.1.3. R&D expertise and technical facilities
7.1.4. Collaborative opportunities
7.1.5. Products and technologies developed
7.1.5.1. Technologies developed
7.1.6. Pharmaceutical and biotechnology opportunities
7.1.7. Contact information
7.2. Indian Institute of Chemical Technology
7.2.1. Overview
7.2.2. R&D focus
7.2.3. R&D expertise and technical facilities
7.2.4. Collaborative opportunities
7.2.5. Products and technologies developed
7.2.6. Key collaborations
7.2.7. Contact information
7.3. National Chemical Laboratory
7.3.1. Overview
7.3.2. R&D focus
7.3.3. R&D expertise and technical facilities
7.3.4. Collaborative opportunities
7.3.5. Key collaborations
7.3.6. Contact information
7.4. Center for Cellular and Molecular Biology
7.4.1. Overview
7.4.2. R&D focus
7.4.3. R&D expertise and technical facilities
7.4.4. Collaborative opportunities
7.4.5. Products and technologies developed
7.4.6. Key collaborations
7.4.7. Contact information
7.5. Institute of Microbial Technology
7.5.1. Overview
7.5.2. R&D focus
7.5.3. R&D expertise and technical facilities
7.5.4. Collaborative opportunities
7.5.5. Products and technologies developed
7.5.6. Key collaborations
7.5.7. Contact information
8. Indian biotechnology: Regional Government initiatives
8.1. Orissa State (Eastern India)
8.1.1. Orissa biotechnology parks
8.2. West Bengal State (Eastern India)
8.3. Gujarat State (Western India)
8.3.1. International Pharma & Biotech Park, Ahmedabad
8.3.1.1. Contact information
8.3.2. Biotechnology park, Vadodra
8.4. Maharashtra State (Western India)
8.4.1. International Biotech Park, Pune
8.4.1.1. Contact information
8.4.2. Jalna Agri Biotech Park, Jalna
8.5. Punjab State (Northern India)
8.5.1. Punjab Biotech Park, Derabassi, near Chandigarh
8.5.1.1. Contact information
8.5.2. Other initiatives
8.6. Haryana State (Northern India)
8.7. Himachal Pradesh State (Northern India)
8.7.1. Biotech parks
8.8. Rajasthan State (Northern India)
8.8.1. Biotechnology park at Sitapura-Jaipur
8.8.1.1. Contact information
8.8.2. Biotechnology park at Boranada, Jodhpur
8.8.3. Biotechnology park at Bhiwadi, Alwar
8.9. Uttar Pradesh State (Northern India
8.9.1. Lucknow biotechnology park, Lucknow
8.9.1.1. Contact information
8.9.2. Biotech City, NOIDA
8.10. Uttaranchal State (Northern India
8.10.1. Biotech park, Pantnagar
8.11. Madhya Pradesh State (Central India
8.12. Karnataka State (Southern India
8.12.1. Bangalore biotechnology park (Bangalore Helix)
8.12.1.1. Contact information
8.13. Kerala State (Southern India)
8.13.1. KINFRA biotech park, Kalamassery
8.13.1.1. Contact information
8.13.2. KINFRA biotechnology park, Trivandrum
8.14. Andhra Pradesh State (Southern India)
8.14.1. ICICI Knowledge Park, Turkapally
8.14.2. Shapoorji Pallonji Biotech Park, Genome Valley, Hyderabad
8.14.2.1. Contact information
8.15. Tamil Nadu State (Southern India)
8.15.1. TICEL Bio Park
8.15.1.1. Contact information
8.15.2. Mahindra Industrial Park, Mahindra City
8.15.1.2. Contact information
9. Appendices
9.1. References
9.2. References
9.3. Abbreviations
9.4. Glossary
9.5. Author biographies
9.5.1. Siraj Dhanani
9.5.2. Amit Sadana
9.5.3. Ashish Malik
9.5.4. PharmARC
CMS, P&A House, Alma Road, Chesham, Bucks. HP5 3HB, UK
Tel: +44 (0)1494 771734
Fax: +44 (0)1494 778994
e-mail: jenniferc@cmsinfo.com
copyright © 2005 all rights reserved
For more information about us, visit CMSinfo.
